This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US DOJ, OSHA warn against non-disclosure agreements that deter antitrust whistleblowers

( January 14, 2025, 22:39 GMT | Official Statement) -- MLex Summary: The US Department of Justice warned that non-disclosure agreements that undermine the Criminal Antitrust Anti-Retaliation Act of 2019, or CAARA, or otherwise interfere with employees’ freedom to report potential crime will cost the employer when the DOJ's antitrust division makes its charging decisions and sentencing recommendations. The DOJ, along with the Department of Labor and the Occupational Safety and Health Administration, said that companies should also be aware that using NDAs to obstruct or impede an investigation may also constitute separate federal criminal violations. "Any company that so interferes with its employees’ cooperation would jeopardize its ability to satisfy its obligations under the Antitrust Division’s leniency policy," the statement said. Statement follows below:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections